Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News ImmuCell Corp ICCC

ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:ICCC)

No current opinion is available.

Bullboard Posts (NDAQ:ICCC)

ImmuCell Corporation (NASDAQ:ICCC): Navigating Challenges, D

http://beyondspx.com/2024/08/01/immucell-corporation-nasdaqiccc-navigating-challenges-driving-growth/
MikeTester - August 1, 2024

it's a buy today for me

at these low prices,so glta shareholders.
coolfooldumbguy - January 21, 2020

trading at book

not a lot of assets that i can find
Craven_Morhead - August 26, 2010

Interview with Mike Brigham

CEO of ImmuCell Corporation, Mike Brigham's interview is now online at Wall Street Reporter website
StockMaster1 - April 25, 2007

DiffGAM

ImmuCell Announces Positive Preliminary Results From Clinical Trial of DiffGAM PORTLAND, Maine--(BW HealthWire)--March 28, 2000...
trade100 - March 28, 2000

TIPS

INP(TSE) 3.12 TO HIT 4.50 MBC(CDNX) 0.41 TO HIT 0.85 MRS(TSE) 3.60 TO HIT 10.00 LII(NYSE) 9.62 TO HIT 15.00 TDE(TSE) 0.16 TO HIT 0.50...
trade100 - March 20, 2000